Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,892 | 377 | 69.8% |
| Consulting Fee | $2,052 | 1 | 18.1% |
| Education | $1,110 | 39 | 9.8% |
| Travel and Lodging | $255.13 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $2,447 | 4 | $0 (2020) |
| Astellas Pharma US Inc | $1,213 | 44 | $0 (2024) |
| ABBVIE INC. | $1,048 | 63 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $674.55 | 27 | $0 (2024) |
| COLOPLAST CORP | $613.16 | 60 | $0 (2024) |
| Janssen Biotech, Inc. | $579.03 | 20 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $452.52 | 20 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $346.19 | 12 | $0 (2024) |
| Boston Scientific Corporation | $316.88 | 11 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $264.95 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $924.10 | 41 | Janssen Biotech, Inc. ($179.41) |
| 2023 | $1,088 | 41 | Bayer Healthcare Pharmaceuticals Inc. ($156.93) |
| 2022 | $1,184 | 50 | Bayer HealthCare Pharmaceuticals Inc. ($305.72) |
| 2021 | $1,603 | 78 | Astellas Pharma US Inc ($503.86) |
| 2020 | $3,431 | 59 | GENZYME CORPORATION ($2,447) |
| 2019 | $1,166 | 64 | Endo Pharmaceuticals Inc. ($153.75) |
| 2018 | $816.70 | 33 | Astellas Pharma US Inc ($152.67) |
| 2017 | $1,097 | 53 | Astellas Pharma US Inc ($233.06) |
All Payment Transactions
419 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/11/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Oncology | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: UROLOGY | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: Oncology | ||||||
| 10/23/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: UROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/27/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/24/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Immunotherapy | ||||||
| 09/18/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Urology Gynecology | ||||||
| 09/04/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Oncology | ||||||
| 08/23/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/26/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 07/19/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: Oncology | ||||||
| 06/14/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Immunotherapy | ||||||
| 06/13/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Continence Care | ||||||
| 06/11/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Oncology | ||||||
| 06/11/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/30/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $44.79 | General |
| Category: UROLOGY | ||||||
| 05/28/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $68.00 | General |
| Category: Oncology | ||||||
| 04/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 5,288 | 9,937 | $1.5M | $577,052 |
| 2022 | 38 | 5,253 | 9,503 | $1.5M | $576,111 |
| 2021 | 35 | 5,432 | 9,413 | $1.5M | $602,961 |
| 2020 | 34 | 3,653 | 6,601 | $1.3M | $486,235 |
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 932 | 1,791 | $299,492 | $126,270 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 523 | 828 | $199,052 | $82,589 | 41.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 272 | 310 | $152,836 | $64,752 | 42.4% |
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 14 | 798 | $119,700 | $53,312 | 44.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 373 | 373 | $132,862 | $46,690 | 35.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 34 | 270 | $114,750 | $36,811 | 32.1% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2023 | 69 | 70 | $58,940 | $23,643 | 40.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 67 | 336 | $29,652 | $15,950 | 53.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 170 | 174 | $44,022 | $15,771 | 35.8% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2023 | 13 | 130 | $37,050 | $13,414 | 36.2% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 69 | 70 | $25,690 | $12,340 | 48.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 64 | 74 | $23,946 | $10,902 | 45.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 774 | 1,151 | $34,122 | $9,746 | 28.6% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 44 | 44 | $25,676 | $8,686 | 33.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 44 | 141 | $21,462 | $6,955 | 32.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 39 | 47 | $15,275 | $5,875 | 38.5% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 98 | 138 | $23,316 | $5,599 | 24.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 1,031 | 2,298 | $32,172 | $5,054 | 15.7% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 15 | 16 | $14,192 | $4,386 | 30.9% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 116 | 124 | $11,937 | $4,351 | 36.4% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 14 | 14 | $7,000 | $3,951 | 56.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 27 | $11,556 | $3,570 | 30.9% |
| 52344 | Repair of stricture of ureter using an endoscope | Facility | 2023 | 16 | 16 | $12,592 | $3,257 | 25.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $5,906 | $2,219 | 37.6% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 69 | 70 | $10,360 | $1,945 | 18.8% |
About Dr. Scott Brown, M.D
Dr. Scott Brown, M.D is a Urology healthcare provider based in La Mesa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477592681.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Brown, M.D has received a total of $11,309 in payments from pharmaceutical and medical device companies, with $924.10 received in 2024. These payments were reported across 419 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($7,892).
As a Medicare-enrolled provider, Brown has provided services to 19,626 Medicare beneficiaries, totaling 35,454 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location La Mesa, CA
- Active Since 06/05/2006
- Last Updated 06/26/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1477592681
Products in Payments
- JEVTANA (Drug) $2,447
- XTANDI (Drug) $664.54
- Nubeqa (Drug) $636.83
- LUPRON DEPOT (Drug) $564.24
- ERLEADA (Drug) $444.26
- PROVENGE (Drug) $380.79
- XIAFLEX (Biological) $325.54
- SpeediCath (Device) $322.32
- ELIGARD (Drug) $289.28
- ORGOVYX (Drug) $271.09
- JELMYTO (Drug) $256.04
- Lupron (Drug) $201.60
- BOTOX (Biological) $185.13
- SPEEDICATH (Device) $160.80
- PYLARIFY (Drug) $156.77
- GENTLECATH (Device) $141.43
- Lupron Depot (Drug) $130.21
- CONTINENCE CARE (Device) $130.04
- REZUM (Device) $126.61
- ADVANCE (Device) $110.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in La Mesa
Paul Dato, M.d, M.D
Urology — Payments: $474,739
Franklin Gaylis, M.d, M.D
Urology — Payments: $122,120
Dr. Mohamed Bidair, M.d, M.D
Urology — Payments: $51,367
Dr. Eileen Byrne, M.d, M.D
Urology — Payments: $14,356
Cameron Wilson, Md, MD
Urology — Payments: $5,719
Wilfred Kearse, M.d, M.D
Urology — Payments: $4,241